topicMilk Thistle Cardiometabolic Meta-Analysis
claimGut microbiota modulation was associated with improved sleep patterns, quality-of-life perception, cytokines expression, and anthropometric parameters post-supplementation.
evidence level2
citationSantamarina AB (2024)
sourceNutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial.
topicMilk Thistle Cardiometabolic Meta-Analysis
claimNutraceutical interventions supporting microbiota and eliciting clinical improvements in metabolic diseases have grown significantly.
evidence level2
citationSantamarina AB (2024)
sourceNutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial.
topicMilk Thistle Cardiometabolic Meta-Analysis
claimChronic stress, gut dysbiosis, and metainflammation have emerged as key factors intertwined with sleep disorders, consequently exacerbating the decline in quality of life.
evidence level2
citationSantamarina AB (2024)
sourceNutraceutical blends predict enhanced health via microbiota reshaping improving cytokines and life quality: a Brazilian double-blind randomized trial.
topicMilk Thistle Cardiometabolic Meta-Analysis
claimMaterial and methods We consecutively enrolled 80 mildly hypercholesterolemic patients with low-density lipoprotein-cholesterol (LDL-C) between 130 and 190 mg/dl with a low-estimated cardiovascular disease risk.
evidence level2
citationFogacci F (2023)
sourceEffect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study.
topicMilk Thistle Cardiometabolic Meta-Analysis
claimIntroduction The scientific community and consumers are increasingly interested in the potential cholesterol-lowering effect of various nutraceuticals and their combinations.
evidence level2
citationFogacci F (2023)
sourceEffect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study.
topicMilk Thistle Cardiometabolic Meta-Analysis
claimThe aim of our study was to test the short-term effect of a new lipid-lowering nutraceutical formulation in mildly hypercholesterolemic patients.
evidence level2
citationFogacci F (2023)
sourceEffect of dietary supplementation with a new nutraceutical formulation on cardiometabolic risk factors: a double-blind, placebo-controlled, randomized clinical study.